Suggestions regarding when it is appropriate to initiate chemotherapy-induced neutropenia prophylaxis in patients with cancer and goals of therapy. January 18th 2021EP. 5: Chemotherapy-Induced ...

Neutropenia is a common adverse effect of cytotoxic chemotherapy. The clinical significance of QOL in patients with chemotherapy-induced neutropenia (CIN) remains largely unexplored, although ...

Overall, these studies highlight the importance of mathematical modeling in enhancing our understanding of chemotherapy-induced neutropenia. By integrating various modeling techniques and patient ...

Chemotherapy-induced neutropenia is a major risk factor for infection-related morbidity and mortality and an important dose-limiting toxicity in cancer treatment. The incidence of severe ...

Managing maximum tolerated dose (MTD) chemotherapy while minimizing neutropenia relies on precise complete blood count (CBC) monitoring and AI-powered diagnostics.

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.

Trilaciclib significantly reduced chemotherapy-induced myelosuppression in extensive ... inhibitor significantly reduced the incidence of severe neutropenia (SN) and associated complications ...

Among the common adverse events with cancer chemotherapy are neutropenia, anemia, nausea and vomiting, mucositis, alopecia, pain, and fatigue.